Switch to:

Strongbridge Biopharma LT-Debt-to-Total-Asset

: 0.00 (As of Mar. 2019)
View and export this data going back to 2015. Start your Free Trial

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Strongbridge Biopharma's long-term debt to total assests ratio for the quarter that ended in Mar. 2019 was 0.00.

Strongbridge Biopharma's long-term debt to total assets ratio declined from Mar. 2018 (0.47) to Mar. 2019 (0.00). It may suggest that Strongbridge Biopharma is progressively becoming less dependent on debt to grow their business.


Strongbridge Biopharma LT-Debt-to-Total-Asset Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Strongbridge Biopharma Annual Data

Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
LT-Debt-to-Total-Asset Premium Member Only 0.00 0.00 0.00 0.36 0.00

Strongbridge Biopharma Quarterly Data

Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
LT-Debt-to-Total-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.50 0.56 0.00 0.00

Strongbridge Biopharma LT-Debt-to-Total-Asset Calculation

Strongbridge Biopharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2018 is calculated as

LT Debt to Total Assets (A: Dec. 2018 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2018 )/Total Assets (A: Dec. 2018 )
=0/170.285
=0.00

Strongbridge Biopharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2019 is calculated as

LT Debt to Total Assets (Q: Mar. 2019 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2019 )/Total Assets (Q: Mar. 2019 )
=0/153.482
=0.00

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Strongbridge Biopharma  (NAS:SBBP) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Strongbridge Biopharma LT-Debt-to-Total-Asset Explanation


Strongbridge Biopharma LT-Debt-to-Total-Asset Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK